| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0071 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0076 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |